Kim Smith Whitley is Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 5,980 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Kim Smith-Whitley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2022
SELL
Sale (or disposition) back to the issuer
-
5,980 Reduced 100.0%
0 Common Stock
Sep 01 2022
SELL
Payment of exercise price or tax liability
$41,367 $68.15 p/Share
607 Reduced 9.21%
5,981 Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
-
2,208 Added 25.1%
6,588 Common Stock
Jun 01 2022
SELL
Payment of exercise price or tax liability
$39,873 $24.02 p/Share
1,660 Reduced 27.48%
4,380 Common Stock
Jun 01 2022
BUY
Exercise of conversion of derivative security
-
6,040 Added 50.0%
6,040 Common Stock
KS

Kim Smith Whitley

Officer
South San Francisco, CA

Track Institutional and Insider Activities on GBT

Follow Global Blood Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT